CAS 32113-41-0

(4-acetamidophenoxy)sulfonyloxypotassium

Description:

(4-Acetamidophenoxy)sulfonyloxypotassium, with the CAS number 32113-41-0, is a chemical compound that features a sulfonate group, which contributes to its solubility in water and potential applications in various chemical processes. The presence of the acetamido group suggests that it may exhibit biological activity, possibly acting as a pharmaceutical intermediate or a reagent in organic synthesis. The phenoxy moiety indicates that it may have properties related to phenolic compounds, which can influence its reactivity and interactions with other substances. As a potassium salt, it is likely to be stable and soluble in polar solvents, making it useful in formulations where ionic strength and solubility are important. Its structural characteristics may also allow it to participate in hydrogen bonding and other intermolecular interactions, which can affect its behavior in biological systems or industrial applications. Overall, this compound's unique functional groups and ionic nature suggest a range of potential uses in both research and industry.

Formula: C₈H₈KNO₅S

InChI: InChI=1/C8H9NO5S.K/c1-6(10)9-7-2-4-8(5-3-7)14-15(11,12)13;/h2-5H,1H3,(H,9,10)(H,11,12,13);/q;+1/p-1/rC8H8KNO5S/c1-6(11)10-7-2-4-8(5-3-7)14-16(12,13)15-9/h2-5H,1H3,(H,10,11)

SMILES: CC(=Nc1ccc(cc1)OS(=O)(=O)O)O.K

Paracetamol sulfate potassium salt

CAS: 32113-41-0

Formula: C₈H₈KNO₅S

Purity: 97%

Color and Shape: Solid

Molecular weight: 269.3161

Ref: IN-DA00C9TP

Paracetamol sulfate potassium salt

CAS: 32113-41-0

Formula: C₈H₈KNO₅S

Molecular weight: 269.32

Ref: 7W-GP7161

Acetaminophen Sulphate Potassium Salt

CAS: 32113-41-0

Formula: C₈H₈NO₅S·K

Color and Shape: Off-White Solid

Molecular weight: 230.22 39.10

Ref: 4Z-A-023

4-Acetaminophen Sulfate Potassium Salt

Controlled Product

CAS: 32113-41-0

Formula: C₈H₈NO₅S·K

Color and Shape: Beige

Molecular weight: 269.32

Ref: TR-A161230

4-Acetaminophen sulfate potassium salt

CAS: 32113-41-0

Acetaminophen-induced hepatotoxicity is a serious adverse effect that can occur with the use of acetaminophen. This drug is metabolized by the liver and excreted in urine as conjugates with glucuronic acid, sulfate, and glutathione. Acetaminophen-induced hepatotoxicity is a major concern for wastewater treatment plants. The potential harm to humans is determined by the plasma concentration of acetaminophen. A pharmacokinetic study was performed on human volunteers to determine the pharmacokinetics of 4-acetaminophen sulfate potassium salt following oral administration. The study found that 4-acetaminophen sulfate potassium salt has linear pharmacokinetics and an activated half-life of 6 hours. This means that it would take 6 hours for 50% of the drug to be eliminated from the body after ingestion. In addition, electrochemical impedance spectroscopy has been used to measure plasma concentrations in humans following oral administration of 4-acetaminohen

Formula: C₈H₈KNO₅S

Purity: Min. 95 Area-%

Color and Shape: Powder

Molecular weight: 269.32 g/mol

Ref: 3D-FA16946

Acetaminophen Sulphate Potassium Salt

CAS: 32113-41-0

Formula: C₈H₈NO₅SK

Molecular weight: 230.22 : 39.10

Ref: ST-EA-CP-A7020